Stock listing
Lang & Schwarz:A40NJY Cybin, Inc. Aktie
German listing (Lang & Schwarz) of Cybin, Inc. · home listing Cboe Canada:HELP
Follow Cybin, Inc. into a list and get an email when it puts out news.
Home listing price · NEO:HELP
$15.01 CAD +0.06 (+0.4%)
Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NEO:HELP
- Day range
- $14.61 – $15.20 CADOct 19, 2026
- Volume
- 5,277 sharesOct 19, 2026
- Market value
- $1.10B CADAt the close on Oct 19, 2026 · price × 73.06M shares outstanding
- Ticker
- Lang & Schwarz:A40NJY
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Oct 15, 2026
Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 45 slides
Latest news
Decks
Investor Presentation (August 2026)
Investor deck · 45 slides · August 2026
Helus Pharma — Technical Presentation (March 2026)
Technical · 20 slides · Mar 5, 2026
Q2 2026 Earnings Presentation
Earnings · 30 slides · Nov 13, 2025
Cybin, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 45 in the last 12 months · 54 in all · newest Oct 15, 2026 · oldest 2021
- Decks
- 3 decks · latest August 2026
Where Cybin, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Cboe Canada:HELP · Home listing | Cboe Canada | Canada | CAD |
| NASDAQ:HELP | NASDAQ | United States | USD |
| gettex:R7E | gettex | Germany | EUR |
| LS Exchange:A40NJY | LS Exchange | Germany | EUR |
| Tradegate:R7E | Tradegate | Germany | EUR |
| BOATS:HELP | BOATS | United States | USD |
| Lang & Schwarz:A40NJY · This page | Lang & Schwarz | Germany | EUR |
| Hamburg:R7E | Hamburg | Germany | EUR |
| Stuttgart:R7E | Stuttgart | Germany | EUR |
| Munich:R7E | Munich | Germany | EUR |
| Frankfurt:R7E | Frankfurt | Germany | EUR |
| Dusseldorf:R7E | Dusseldorf | Germany | EUR |
Log in to ask 6ix AI your own questions about Cybin, Inc.